The association between mycoplasma infections and atherosclerosis: Myth or clinical reality?

Israel Medical Association Journal

Volumn 12, Issue 7, 2010, Pages 439-440

  Nussinovitch, Udi ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY TITER; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; AUTOIMMUNITY; CHLAMYDOPHILA PNEUMONIAE; COMPLEMENT FIXATION TEST; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DISEASE COURSE; EDITORIAL; ELECTRON MICROSCOPY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART INFARCTION; HUMAN; MYCOPLASMA PNEUMONIAE; MYCOPLASMOSIS; NONHUMAN; POLYMERASE CHAIN REACTION; SEROPREVALENCE; TISSUE INJURY; ANIMAL; COMPLICATION;

ANIMALS; ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; HUMANS; MYCOPLASMA INFECTIONS;

EID: 77955083640     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (16)

1. Nussinovitch U, Shoenfeld Y. Autoimmunity and heart diseases: pathogenesis and diagnostic criteria. Arch Immunol Ter Exp (Warsz) 2009; 57: 95-104.
2. Higuchi ML, Sambiase N, Palomino S, et al. Detection of Mycoplasma pneumoniae and Chlamydia pneumoniae in ruptured atherosclerotic plaques. Braz J Med Biol Res 2000;33: 1023-1026.
3. Fujinami RS, von Herrath MG, Christen U, Whitton JL. Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease. Clin Microbiol Rev 2006; 19: 80-94.
4. Maia IL, Nicolau JC, Machado Mde N, et al. Prevalence of Chlamydia pneumoniae and Mycoplasma pneumoniae in diferent forms of coronary disease. Arq Bras Cardiol 2009; 92: 405-411.
5. Weiss TW, Kvakan H, Kaun C, et al. No evidence for a direct role of Helicobacter pylori and Mycoplasma pneumoniae in carotid artery atherosclerosis. J Clin Pathol 2006; 59: 1186-1190.
6. Espinola-Klein C, Rupprecht HJ, Blankenberg SB, et al. Impact of infectious burden on extent and long-term prognosis of atherosclerosis. Circulation 2002; 105: 15-21.
7. Damy SB, Higuchi ML, Timenetsky J, et al. Mycoplasma pneumoniae and/or Chlamydophila pneumoniae inoculation causing diferent aggravations in cholesterol-induced ather- osclerosis in apoE KO male mice. BMC Microbiol 2009; 9: 194.
8. Momiyama Y, Ohmori R, Taniguchi H, Nakamura H, Ohsuzu F. Association of Mycoplasma pneu- moniae infection with coronary artery disease and its interaction with chlamydial infection. Atherosclerosis. 2004; 176: 139-144.
9. Higuchi Mde L, Reis MM, Sambiasi NV, et al. Coinfection with Mycoplasma pneumoniae and Chlamydia pneumoniae in ruptured plaques associated with acute myocardial infarction. Arq Bras Cardiol 2003; 81: 12-22.
10. Reszka E, Jegier B, Wasowicz W, Lelonek M, Banach M, Jaszewski R. Detection of infectious agents by polymerase chain reaction in human aortic wall. Cardiovasc Pathol 2008; 17: 297-302.
11. Goyal P, Kalek SC, Chaudhry R, Chauhan S, Shah N. Association of common chronic infections with coronary artery disease in patients without any conventional risk factors. Indian J Med Res 2007; 125: 129-136.
12. Reunanen A, Roivainen M, Kleemola M, et al. Enterovirus, mycoplasma and other infections as predictors for myocardial infarction. J Intern Med 2002; 252: 421-9.
13. Barski L, Nevzorov R, Horowitz J, Horowitz S. Antibodies to various mycoplasmas in patients with coronary heart disease. IMAJ Isr M Assoc J 2010; 12: 369-9.
14. Espinola-Klein C, Rupprecht HJ, Blankenberg S, et al. Impact of infectious burden on progression of carotid atherosclerosis. Stroke 2002; 33: 2581-2586.
15. Petitjean J, Vabret A, Gouarin S, Freymuth F. Evaluation of four commercial immunoglobulin G (IgG)- and IgM-specifc enzyme immunoassays for diagnosis of Mycoplasma pneumoniae infections. J Clin Microbiol 2002; 40: 165-171.
16. Csángó PA, Pedersen JE, Hess RD. Comparison of four Mycoplasma pneumoniae IgM-, IgG- and IgA-specifc enzyme immunoassays in blood donors and patients. Clin Microbiol Infect 2004; 10: 1094109-8.